Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - moxonidine, quantity: 200 microgram - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; crospovidone; povidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - moxonidine, quantity: 400 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; crospovidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - moxonidine, quantity: 200 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; crospovidone; magnesium stearate; povidone; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - moxonidine gh is indicated for the treatment of hypertension

Australia - English - Department of Health (Therapeutic Goods Administration)

lupin australia pty limited - moxonidine, quantity: 400 microgram - tablet, film coated - excipient ingredients: magnesium stearate; crospovidone; lactose monohydrate; povidone; titanium dioxide; hypromellose; iron oxide red; macrogol 400 - moxonidine gh is indicated for the treatment of hypertension

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - moxonidine, quantity: 200 microgram - tablet, film coated - excipient ingredients: povidone; lactose monohydrate; magnesium stearate; crospovidone; titanium dioxide; hypromellose; purified talc; macrogol 6000; iron oxide red - moxotens is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - moxonidine, quantity: 400 microgram - tablet, film coated - excipient ingredients: crospovidone; magnesium stearate; lactose monohydrate; povidone; titanium dioxide; hypromellose; purified talc; macrogol 6000; iron oxide red - moxotens is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moxonidine, quantity: 0.4 mg - tablet, film coated - excipient ingredients: crospovidone; lactose monohydrate; ethylcellulose; titanium dioxide; povidone; macrogol 6000; hypromellose; purified talc; magnesium stearate; iron oxide red - for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moxonidine, quantity: 0.3 mg - tablet, film coated - excipient ingredients: crospovidone; titanium dioxide; lactose monohydrate; magnesium stearate; povidone; purified talc; ethylcellulose; iron oxide red; macrogol 6000; hypromellose - for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

viatris pty ltd - moxonidine, quantity: 0.2 mg - tablet, film coated - excipient ingredients: magnesium stearate; macrogol 6000; povidone; ethylcellulose; crospovidone; purified talc; iron oxide red; titanium dioxide; hypromellose; lactose monohydrate - for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

sanofi-aventis australia pty ltd - alfuzosin hydrochloride, quantity: 10 mg - tablet, modified release - excipient ingredients: magnesium stearate; ethylcellulose; microcrystalline cellulose; iron oxide yellow; silicon dioxide; mannitol; hypromellose; hydrogenated castor oil; povidone - indicated for the treatment of the functional symptoms of benign prostatic hyperplasia.